Investors

The Common Stock of BioClinica, Inc. is listed on the NASDAQ Global Market under the symbol BIOC.

SIC Number: 8071
CIK Number: 0000822418
CUSIP Number: 09071B 100
Share Data at September 30,2009
Authorized: 36,000,000
Outstanding: 14,392,145
Symbol: BIOC
Exchange: NASDAQ

 

 

Listen to the webcast of the BioClinica fourth quarter and year end 2009 financial results on Feburary 10, 2010.  This will be available for two weeks after the call.

Mark Weinstein contributes to “The Wall Street Transcript. Connecting Market Leaders with Investors.”

BioClinica will be presenting at the Jefferies 2010 Global Healthcare Services Conference on January 25-27, 2010 at the Mandarin Oriental Hotel in New York, NY.  To view the webcast of this presentation, please click here.  The webcast will be available for 90 days after the conference.

For more investment information, please contact us at ir@bioclinica.com

Click here to view our Analyst Coverage, Transfer Agent, Company Counsel and Independent Auditors.